Related references
Note: Only part of the references are listed.Contributive Role of TNF-α to L-DOPA-Induced Dyskinesia in a Unilateral 6-OHDA Lesion Model of Parkinson's Disease
Mauricio dos Santos Pereira et al.
FRONTIERS IN PHARMACOLOGY (2021)
Doxycycline and its derivative, COL-3, decrease dyskinesia induced by l-DOPA in hemiparkinsonian rats
Mariza Bortolanza et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Doxycycline Interferes With Tau Aggregation and Reduces Its Neuronal Toxicity
Luciana Medina et al.
FRONTIERS IN AGING NEUROSCIENCE (2021)
The efficacy of systemic administration of lipopolysaccharide in modelling pre-motor Parkinson's disease in C57BL/6 mice
Isaac Deng et al.
NEUROTOXICOLOGY (2021)
Cannabidiol prevents LPS-induced microglial inflammation by inhibiting ROS/NF-κB-dependent signaling and glucose consumption
Mauricio dos-Santos-Pereira et al.
GLIA (2020)
Spinal neuronal excitability and neuroinflammation in a model of chemotherapeutic neuropathic pain: targeting the resolution pathways
Pongsatorn Meesawatsom et al.
JOURNAL OF NEUROINFLAMMATION (2020)
CMT-3 targets different α-synuclein aggregates mitigating their toxic and inflammogenic effects
Florencia L. Gonzalez-Lizarraga et al.
SCIENTIFIC REPORTS (2020)
Acute glucose fluctuation impacts microglial activity, leading to inflammatory activation or self-degradation
Cheng-Fang Hsieh et al.
SCIENTIFIC REPORTS (2019)
Nerve Growth Factor modulates LPS - induced microglial glycolysis and inflammatory responses
Georgia Fodelianaki et al.
EXPERIMENTAL CELL RESEARCH (2019)
Rifampicin and Its Derivative Rifampicin Quinone Reduce Microglial Inflammatory Responses and Neurodegeneration Induced In Vitro by α-Synuclein Fibrillary Aggregates
Leonardo Acuna et al.
CELLS (2019)
Cytosolic ROS production by NADPH oxidase 2 regulates muscle glucose uptake during exercise
Carlos Henriquez-Olguin et al.
NATURE COMMUNICATIONS (2019)
Dexamethasone inhibits inflammatory response via down regulation of AP-1 transcription factor in human lung epithelial cells
Rajeshwari H. Patil et al.
GENE (2018)
Tetracycline repurposing in neurodegeneration: focus on Parkinson's disease
Mariza Bortolanza et al.
JOURNAL OF NEURAL TRANSMISSION (2018)
Microglial glutamate release evoked by α-synuclein aggregates is prevented by dopamine
Mauricio dos-Santos-Pereira et al.
GLIA (2018)
Novel Antioxidant Properties of Doxycycline
Dahn L. Clemens et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Tetracyclines Modify Translation by Targeting Key Human rRNA Substructures
Jonathan D. Mortison et al.
CELL CHEMICAL BIOLOGY (2018)
A presumed antagonistic LPS identifies distinct functional organization of TLR4 in mouse microglia
Christin Doering et al.
GLIA (2017)
Doxycycline attenuates breast cancer related inflammation by decreasing plasma lysophosphatidate concentrations and inhibiting NF-κB activation
Xiaoyun Tang et al.
MOLECULAR CANCER (2017)
Doxycycline directly targets PAR1 to suppress tumor progression
Weilong Zhong et al.
ONCOTARGET (2017)
Repurposing doxycycline for synucleinopathies: remodelling of α-synuclein oligomers towards non-oxic parallel beta-sheet structured species
Florencia Gonzalez-Lizarraga et al.
SCIENTIFIC REPORTS (2017)
Dexamethasone rapidly inhibits glucose uptake via non-genomic mechanisms in contracting myotubes
Hong Gong et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2016)
A Simplified Approach for Efficient Isolation of Functional Microglial Cells: Application for Modeling Neuroinflammatory Responses In Vitro
Julia E. Sepulveda-Diaz et al.
GLIA (2016)
Doxycycline Suppresses Microglial Activation by Inhibiting the p38 MAPK and NF-kB Signaling Pathways
Flavia V. Santa-Cecilia et al.
NEUROTOXICITY RESEARCH (2016)
Redox Regulation of NF-κB p50 and M1 Polarization in Microglia
Thomas Taetzsch et al.
GLIA (2015)
Doxycycline restrains glia and confers neuroprotection in a 6-OHDA Parkinson model
Marcio Lazzarini et al.
GLIA (2013)
Matrix Metalloproteinase Inhibitor COL-3 Prevents the Development of Paclitaxel-Induced Hyperalgesia in Mice
Subramanian S. Parvathy et al.
MEDICAL PRINCIPLES AND PRACTICE (2013)
COL-3, a Chemically Modified Tetracycline, Inhibits Lipopolysaccharide-Induced Microglia Activation and Cytokine Expression in the Brain
Rawan Abdulhameed Edan et al.
PLOS ONE (2013)
The Iron-Binding Protein Lactoferrin Protects Vulnerable Dopamine Neurons from Degeneration by Preserving Mitochondrial Calcium Homeostasis
Erwann Rousseau et al.
MOLECULAR PHARMACOLOGY (2013)
Neuroprotective Effects of Tetracyclines: Molecular Targets, Animal Models and Human Disease
D. Orsucci et al.
CNS & Neurological Disorders-Drug Targets (2012)
Evaluation of the antioxidant activity of tetracycline antibiotics in vitro
Aleksandra Kladna et al.
LUMINESCENCE (2012)
Role of Matrix Metalloproteinases and Therapeutic Benefits of Their Inhibition in Spinal Cord Injury
Haoqian Zhang et al.
NEUROTHERAPEUTICS (2011)
Tetracyclines and Chemically Modified Tetracycline-3 (CMT-3) Modulate Cytokine Secretion by Lipopolysaccharide-Stimulated Whole Blood
Julia Cazalis et al.
INFLAMMATION (2009)
Doxycycline is Neuroprotective Against Nigral Dopaminergic Degeneration by a Dual Mechanism Involving MMP-3
Yuri Cho et al.
NEUROTOXICITY RESEARCH (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology
Karen Bedard et al.
PHYSIOLOGICAL REVIEWS (2007)
Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi's sarcoma: An AIDS Malignancy Consortium study
BJ Dezube et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Tetracyclines: Nonantibiotic properties and their clinical implications
AN Sapadin et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Interactive role of the toll-like receptor 4 and reactive oxygen species in LPS-induced microglia activation
LY Qin et al.
GLIA (2005)
Aggregated α-synuclein activates microglia:: a process leading to disease progression in Parkinson's disease
W Zhang et al.
FASEB JOURNAL (2005)
A phase I and pharmacokinetic study of Col-3 (metastat), an oral tetracycline derivative with potent matrix metalloproteinase and antitumor properties
S Syed et al.
CLINICAL CANCER RESEARCH (2004)
Dependence of α-synuclein aggregate morphology on solution conditions
W Hoyer et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
Crystal structures of complexes of the small ribosomal subunit with tetracycline, edeine and IF3
M Pioletti et al.
EMBO JOURNAL (2001)
Phase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer
MA Rudek et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
